Projects per year
Personal profile
Biography
Karen is a Research Fellow in the Faculty of Business and Economics at Monash University. She has over ten years of experience evaluating the clinical- and cost-effectiveness of medical technologies for funding on national insurance schemes. This includes the development of modelled economic evaluations as well as reviews of funded technologies to ensure continued value for money. Her work has directly informed recommendations by the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) in Australia, and the Agency for Care Effectiveness (ACE) in Singapore.
Other research interests include economic modelling, funding decisions by health technology assessment committees, including using drug reimbursement data in Australia.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Economic modelling
- Pharmaceuticals
- Cost Utility Analysis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Monitoring system for final trial overall survival (OS) results for cancer medicines
Li, J. J. (Primary Chief Investigator (PCI)), Sia, K. L. (Chief Investigator (CI)), Ghijben, P. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Picton, L. (Chief Investigator (CI)), Yong, K. (Chief Investigator (CI)), Chen, E. (Chief Investigator (CI)) & Ayati, N. (Chief Investigator (CI))
24/06/24 → 30/04/25
Project: Research
-
CSR: Cancer Surrogate Report for the PBAC
Li, J. J. (Primary Chief Investigator (PCI)), Sia, K. L. (Chief Investigator (CI)), Yong, K. (Chief Investigator (CI)), Ghijben, P. (Chief Investigator (CI)), Chen, E. (Chief Investigator (CI)) & Petrie, D. (Chief Investigator (CI))
17/10/22 → 31/12/23
Project: Research
-
MSAC ID 1712-PICO Confirmation - Out-of-laboratory sleep studies in the diagnosis and management of sleep disordered breathing in children and adolescents
Li, J. J. (Primary Chief Investigator (PCI)), Sia, K. L. (Chief Investigator (CI)), Yong, K. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))
27/05/22 → 15/09/22
Project: Research
-
MSAC Development of ADAR Commentary
Li, J. J. (Primary Chief Investigator (PCI)), Irving, A. (Associate Investigator (AI)), Petrie, D. (Chief Investigator (CI)) & Yong, K. (Associate Investigator (AI))
22/06/21 → 31/12/21
Project: Research
-
A Review of Cancer Related Surrogate Outcomes Used For PBAC Decision Making: The Cancer Surrogate Report for the PBAC
Sia, K.-L., Picton, L., Chen, E., Yong, K., Petrie, D., Ghijben, P., Mohanannair Geethadevi, G., Winn, K. M., Crothers, A. & Li, J. J., Jul 2023, Australia: Commonwealth Department of Health and Aged Care. 85 p.Research output: Book/Report › Commissioned Report › Other
Open Access -
What can we expect from value-based funding of medicines? A retrospective study
Harris, A. H., Li, J. J. & Yong, K. K. L., 2016, In: PharmacoEconomics. 34, 4, p. 393 - 402 10 p.Research output: Contribution to journal › Article › Research › peer-review
11 Citations (Scopus) -
Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada
Clement, F., Harris, A. H., Li, J. J., Yong, K. K. L., Lee, K. & Manns, B., 2009, In: JAMA. 302, 13, p. 1437 - 1443 7 p.Research output: Contribution to journal › Article › Research › peer-review
296 Citations (Scopus) -
An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness
Harris, A., Yong, K. & Kermode, M., 2001, In: Australian and New Zealand Journal of Public Health. 25, 3, p. 222 - 229 8 p.Research output: Contribution to journal › Article › Research › peer-review
18 Citations (Scopus) -
Relative influence of Quality of Life and survival in cost-utility analysis
Defina, J., Yong, K., Harris, A. & Kolivos, A., 2000, p. 17 - 29. 13 p.Research output: Contribution to conference › Other